You are here

News

CHU de Québec Collaborates with PerkinElmer on a study funded by Genome Canada, Génome Québec, CIHR and Genome Alberta using DNA sequencing alone or in a contingent model with first trimester serum markers as non-invasive option to determine risk of Down

Monday, November 4, 2013

A team of clinical researchers led by CHU de Québec has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.

Call for proposals for the biobank of the Canadian Health Measures Survey

Friday, November 1, 2013

From November 1 to December 31, 2013, Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Canadian Health Measures Survey (CHMS) for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.

Genome Canada welcomes five new Board members

Wednesday, October 30, 2013

Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:

Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University

Jay Ingram, Broadcaster and Science Writer

Kim McConnell, Founder and former CEO, AdFarm

Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia

Donald Ziraldo, Co-founder, Inniskillin Wines

The Structural Genomics Consortium Announces that Janssen has joined its Public-Private Drug Discovery Partnership

Friday, October 25, 2013

The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.

Pages